| IV-13 Marylore Chenel Physiologically based pharmacokinetic (PBPK) modelling of cabotegravir (CAB) to support design of microarray patches (MAPs) for the treatment of HIV positive children Thursday 15:00-16:30 |
| IV-13 Marylore Chenel Physiologically based pharmacokinetic (PBPK) modelling of cabotegravir (CAB) to support design of microarray patches (MAPs) for the treatment of HIV positive children Thursday 15:00-16:30 |